Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

AM-095 displays antifibrotic activity in vivo

Jan. 13, 2011

AZD-9773 enters phase IIb trial in patients with severe sepsis and/or septic shock

Oct. 26, 2010

Almirall identifies new naphthyridine N-oxide as anti-inflammatory agent

Sep. 21, 2010

Positive outcome to decentralized procedure for European approval of Twinject

Sep. 1, 2010

Novel LPA1 receptor antagonists developed at Amira

July 7, 2010

Omeros selects clinical candidate for MASP-2 antibody program

May 14, 2010

Osiris achieves milestone for remestemcel-L development progress in Japan

April 29, 2010

DMC recommends continued enrollment in eritoran phase III trial for severe sepsis

March 26, 2010

Phase I trial of deferoxamine in acute cerebral hemorrhage currently recruiting participants

March 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...